human
tonsil
sampl
obtain
consecut
routin
tonsillectomi
patient
age
without
report
allergi
satakunta
central
hospit
pori
finland
inclus
criteria
elect
tonsillectomi
accord
clinic
indic
written
inform
consent
studi
subject
hisher
parent
studi
protocol
approv
ethic
committe
satakunta
central
hospit
pori
finland
standard
questionnair
use
obtain
inform
allerg
diseas
respiratori
symptom
within
day
oper
tabl
tonsillectomi
perform
accord
routin
clinic
procedur
tonsil
store
rnalat
rna
stabil
reagent
qiagen
hilden
germani
anesthesia
nasopharyng
aspir
also
obtain
use
standard
procedur
store
detail
shown
supplementari
method
viral
diagnost
naiv
nasopharyng
aspir
intratonsilar
sampl
perform
accord
clinic
routin
use
pcr
adenoviru
coronavirus
enterovirus
influenza
b
virus
metapneumoviru
parainfluenza
viru
type
respiratori
syncyti
viru
rhinoviru
sampl
polyomavirus
ki
wu
sampl
gene
express
tbet
analyz
quantit
pcr
appli
biosystem
foster
citi
ca
usa
detail
see
suppl
method
tabl
addit
convent
statist
linear
logist
regress
use
analyz
associ
viru
detect
age
atop
characterist
version
sa
institut
inc
cari
nc
usa
agreement
statist
intratonsillar
nasopharyng
viru
diagnost
calcul
kappa
coeffici
heatmap
partial
spearman
correl
gene
express
comput
differ
diseas
group
control
age
differ
correl
accord
diseas
group
analyz
use
procedur
develop
fisher
statist
signific
correl
also
display
network
represent
cytoscap
softwar
http
wwwcytoscapeorg
statist
signific
establish
level
p
detail
suppl
method
tonsil
nasopharyng
aspir
sampl
obtain
routin
tonsillectomi
patient
patient
characterist
shown
tabl
briefli
median
age
studi
subject
year
report
allergi
oper
carri
cold
phase
chronic
tonsil
condit
main
indic
tonsillectomi
hypertroph
tonsil
andor
recurr
tonsil
tabl
median
last
day
respiratori
symptom
day
oper
exclud
sore
throat
subject
due
oper
indic
medic
data
shown
suppl
result
percent
nasopharyng
aspir
posit
virus
virus
fig
tabl
rhinoviru
preval
viru
follow
adenoviru
enterovirus
coronaviru
virus
percentag
tonsillar
sampl
posit
virus
virus
adenoviru
enterovirus
found
follow
parainfluenza
viru
virus
nasopharyng
intratonsillar
viru
detect
rate
decreas
age
p
nasopharyng
sampl
clear
virus
age
tonsillar
sampl
age
exclud
one
case
fig
nasopharyng
sampl
rhinoviru
adenoviru
one
viru
detect
rate
decreas
age
p
tonsillar
sampl
enteroviru
adenoviru
parainfluenza
viru
viru
rate
decreas
age
p
enteroviru
viru
detect
show
agreement
nasopharyng
intratonsillar
sampl
kappa
coeffici
confid
interv
tabl
intratonsillar
mrna
express
level
analyz
cytokin
transcript
factor
list
tabl
increas
age
show
signific
neg
correl
tbet
mrna
express
tonsil
p
fig
show
correl
investig
cytokin
transcript
factor
fig
allerg
diseas
consid
atop
dermat
associ
higher
express
tonsil
associ
remain
signific
adjust
age
p
fig
invers
correl
age
seen
patient
without
atop
dermat
r
p
atop
dermat
p
cytokin
transcript
factor
data
associ
clinic
factor
shown
tabl
brief
allergi
associ
lower
tbet
express
lower
ratio
remain
signific
adjust
age
p
allerg
rhiniti
associ
lower
express
asthma
associ
lower
express
p
adjust
age
addit
respiratori
symptom
within
last
week
tonsillectomi
correl
neg
express
mean
differ
confid
interv
p
rhinoviru
detect
independ
associ
higher
tonsil
p
fig
intratonsillar
viru
detect
overal
number
detect
virus
rhinoviru
detect
parainfluenza
viru
detect
independ
associ
high
tbet
express
p
adjust
age
allergi
fig
signific
univari
associ
intratonsillar
viru
detect
express
remain
signific
multivari
model
age
andor
atop
dermat
remain
signific
adjust
fig
express
independ
neg
associ
nasopharyng
andor
tonsillar
viru
detect
p
associ
cytokin
transcript
factor
data
virolog
fulli
detail
tabl
fig
b
studi
enabl
us
investig
correl
express
cytokin
transcript
factor
directli
analyz
tonsil
without
cell
cultur
repres
vivo
situat
express
close
posit
correl
tbet
express
p
fig
contrast
neg
correl
observ
tonsil
consid
p
correl
illustr
heatmap
fig
overal
two
cluster
show
high
posit
intraclust
correl
observ
antivir
cluster
immun
activationregulatori
cluster
tbet
see
overal
data
fig
two
cluster
show
strong
neg
correl
exclud
appear
intermediari
link
antivir
immun
respons
gener
immun
respons
interestingli
correl
antivir
gene
less
promin
presenc
viru
four
key
th
cell
transcript
factor
name
tbet
show
strong
posit
correl
immun
regulatori
treg
factor
also
close
posit
correl
presenc
tonsillar
andor
nasopharyng
viral
infect
induc
strong
neg
correl
antivir
cluster
cytokin
regulatori
cluster
mostli
disappear
absenc
viru
fig
neg
correl
particularli
antivir
cluster
promin
presenc
viru
disappear
absenc
viru
interestingli
cytokin
consist
appear
antivir
cluster
show
strong
posit
correl
antivir
cytokin
show
pronounc
neg
correl
regulatori
cluster
presenc
tonsillar
viru
allergi
posit
correl
antivir
cytokin
significantli
decreas
presenc
viru
exist
allergi
also
modestli
deepen
neg
relationship
immun
regulatori
antivir
cluster
compar
individu
without
allergi
fig
interestingli
allergi
associ
strong
posit
correl
tbet
wherea
posit
correl
nonallerg
patient
disappear
presenc
allergi
correl
shown
detail
tabl
gene
network
graph
fig
illustr
antivir
regulatori
cluster
diseas
state
viru
infect
allergi
neg
interrel
exclud
posit
connect
shown
fig
overal
distinct
two
cluster
significantli
increas
presenc
tonsillar
viru
clinic
allergi
studi
provid
new
insight
immun
regul
antivir
respons
human
tonsil
relat
age
infect
allerg
ill
interestingli
intratonsillar
viru
detect
strongli
decreas
age
one
case
found
age
network
analys
show
two
main
cluster
antivir
immun
cluster
two
cluster
strong
neg
interclust
correl
becam
distinct
presenc
viral
infect
report
allergi
remark
allergi
influenc
mani
interact
markedli
deepen
neg
relationship
antivir
immun
activationregulatori
cluster
fine
balanc
activ
vs
toler
lie
express
intens
cell
vs
treg
cell
human
tonsil
inde
chang
correl
found
tbet
relat
allergi
interestingli
newli
discov
cytokin
posit
associ
atop
dermat
subject
allergi
show
lower
express
lower
innat
immun
respons
without
allergi
presenc
asthma
neg
associ
type
iiii
interferon
agreement
previou
vivo
data
role
formerli
famili
member
respiratori
viral
infect
allergi
develop
previous
studi
previous
demonstr
natur
suppressor
innat
inflammatori
immun
respons
vitro
anim
studi
data
may
suggest
may
inhibit
express
shown
previous
regulatori
cell
agreement
show
posit
correl
find
express
independ
posit
associ
atop
dermat
nonindepend
posit
associ
viru
infect
could
impli
inflammatori
state
gener
viral
infect
like
increas
express
similar
express
sever
isoform
exist
primer
set
cover
moreov
produc
precursor
need
activ
caspas
therefor
relationship
mrna
express
biolog
activ
necessarili
direct
one
key
find
present
studi
fell
apart
typic
activ
respons
unexpectedli
show
strong
correl
cluster
antivir
cytokin
becam
particularli
signific
presenc
tonsillar
viru
allergi
statu
find
may
help
explain
role
exacerb
asthma
interestingli
data
suggest
differ
way
regul
contrast
viru
infect
releas
togeth
antivir
interferon
may
reduc
extent
inflamm
tissu
injuri
inhibit
monocyt
macrophag
product
proinflammatori
factor
data
scarc
disconnect
viral
infect
specif
viral
infect
may
either
decreas
increas
express
cytokin
moreov
may
induc
express
receptor
lead
consequenti
suppress
respons
network
analys
reveal
viru
infect
also
associ
mani
alter
interact
similar
allergi
light
recent
demonstr
break
toler
human
tonsil
trigger
receptor
tlr
proinflammatori
cytokin
specul
viral
infect
may
import
role
break
peripher
toler
therebi
promot
develop
exacerb
allerg
diseas
rhinoviru
particularli
interest
regard
import
trigger
wheez
asthma
especi
atop
individu
demonstr
new
find
intratonsillar
viru
especi
rhinoviru
parainfluenzaviru
detect
independ
posit
associ
type
express
mainli
control
tbet
import
antivir
activ
capac
downregul
type
respons
exist
viru
infect
allergi
increas
complex
gene
network
interestingli
diseas
condit
similar
polar
influenc
overal
correl
profil
neg
correl
antivir
regulatori
gene
particularli
observ
presenc
viru
proinflammatori
cytokin
downregul
like
limit
inflamm
remark
posit
interact
antivir
regulatori
cluster
search
covari
found
age
show
low
neg
correl
express
sever
gene
virus
tonsil
high
age
compon
immun
affect
cell
suscept
virolog
follicular
helper
cell
possibl
cellular
sourc
investig
gene
potenti
limit
studi
discuss
detail
suppl
discuss
taken
togeth
present
studi
provid
sever
new
potenti
import
find
consid
tonsil
new
vivo
model
understand
immun
respons
develop
immun
toler
induct
intranod
immunotherapi
demonstr
highli
effect
data
need
basic
immun
mechan
lymphnoid
tj
laboratori
support
academi
finland
grant
finnish
medic
foundat
sigrid
juseliu
foundat
foundat
pediatr
research
op
ramon
cajal
scholar
fund
mineco
european
social
fund
laboratori
sponsor
eu
framework
program
predicta
immun
reprogram
associ
persist
chronic
respiratori
allerg
diseas
caa
laboratori
support
swiss
nation
scienc
foundat
grant
christin
allergi
research
educ
dr
jartti
akdi
c
particip
suffici
work
take
public
respons
whole
content
jartti
palomar
akdi
c
contribut
studi
concept
design
jartti
palomar
wari
nieminen
puhakka
aab
vuorinen
alland
akdi
akdi
c
involv
acquisit
data
jartti
palomar
tastan
vahlberg
akdi
akdi
c
involv
analysi
interpret
data
jartti
palomar
tastan
vahlberg
akdi
akdi
c
draft
manuscript
jartti
palomar
wari
tastan
nieminen
puhakka
aab
vuorinen
alland
vahlberg
ruuskanen
akdi
akdi
c
involv
critic
revis
manuscript
import
intellectu
content
jartti
palomar
vuorinen
akdi
akdi
c
provid
administr
technic
materi
support
akdi
c
supervis
studi
author
declar
conflict
interest
